Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Garcia Weight Loss, Aesthetics & Hormone Therapy vs LVNG RX

vs+3.1000000000000014
LVNG RX
Graded #268

Higher grade

The verdict

LVNG RX takes it — 62.5/100 to 59.4/100.

LVNG RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LVNG RX is a Delaware-registered telehealth platform (LVNG RX LLC) offering compounded semaglutide from $149/mo and tirzepatide from $249/mo, plus a lower-dose GLP-1 microdose program.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLVNG RX +34
30
64
Dose & formulationLVNG RX +12
52
64
Clinical oversightGarcia Weight Loss, Aesthetics & Hormone Therapy +23
79
56
Labs & monitoringGarcia Weight Loss, Aesthetics & Hormone Therapy +35
97
62
FulfillmentLVNG RX +13
56
69
Contract termsLVNG RX +6
55
61
Garcia Weight Loss, Aesthetics & Hormone Therapy · left barLVNG RX · right bar

The numbers

MetricGarcia Weight Loss, Aesthetics & Hormone TherapyLVNG RX
WeighScore59.4/10062.5/100
GradeCC
Scorecard rank#342#268
Semaglutide$400/mo (starting dose, compounded)$149/mo (starting dose, compounded)
TirzepatideNot disclosed$249/mo (microdose tier, starting dose, compounded)
Coverage1 stateCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Strengths

  • Established since 2000 with 4 Tampa Bay locations and 50,000+ patients treated
  • GLP-1 program includes full metabolic and hormone lab panel
  • Medication and supplies shipped directly to your door from partner pharmacy
  • Free 15-minute consultation; both weekly-visit (Premier) and monthly-visit (Standard) tiers
  • LegitScript transparency certification listed in footer

Where it loses points

  • Florida only — 4 locations in Tampa Bay metro area only
  • Pricing not publicly listed on website ($400/month per Facebook ad)
  • Specific GLP-1 drug (semaglutide vs tirzepatide) not disclosed on site
  • Telemedicine availability not confirmed on site despite Facebook ad claims
  • In-person visit model less convenient than fully online telehealth providers
LVNG RX

Graded #268 · C

Strengths

  • One bundled price covers the provider visit, prescription, shipping and ongoing check-ins, with zero consultation charges
  • States you are charged nothing if a provider does not approve you for treatment
  • Promises no dose-change surcharges — 'the price we quote is the price you pay, period'
  • Semaglutide from $149/mo is competitive against the wider compounded market
  • Offers a lower-dose GLP-1 microdose program alongside standard semaglutide and tirzepatide

Where it loses points

  • Displays a Trustpilot 'Rated Excellent 4.8 / 5' badge, but no Trustpilot profile exists for the domain or the brand
  • Also claims '4.9 based on 300+ Google reviews'; no Google listing for the business could be located
  • Its own homepage figures conflict — '10k+' members in the hero versus '1,743+ patients supported' in the counters below
  • The actual plan price is confirmed only after provider review, and the three treatment pages publish no prices at all
  • No compounding pharmacy, medical group or individual clinician is named anywhere on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard